About CVRx | Barostim
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body’s own natural blood flow regulation system - which signals the brain to regulate cardiovascular function.
Patient Stories on CVRx:
The accounts and quotes of patients are genuine and documented. These stories represent a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to CVRx technologies.
Barostim is a prescriptive device. For a list of all potential benefits and risks go to www.cvrx.com/benefit-risk-analysis/
|
|
|
201-500 employees
View all CVRx | Barostim employees
|
|
Medical Devices
|
|
Minneapolis, MN 55445, US
|
|
2001
|
CVRx | Barostim Alternatives
Frequently Asked Questions about CVRx | Barostim
Kelly M Lamotte is the CEO of CVRx. To contact Kelly M Lamotte email at [email protected].
The decision makers in CVRx | Barostim are Ivana Stojanovic, Jonelle Burnham, Kevin Hykes, etc. Click to Find CVRx | Barostim decision makers emails.
CVRx | Barostim Staff Directory
Search CVRx | Barostim Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
